These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6441843)

  • 1. Synthesis and evaluation of novel N-substituted N'-(3-hydroxy-17-oxoestra-1,3,5(10)-trien-2- and -4-yl)thiourea derivatives for binding to the estrogen receptor and cytotoxic activity on MCF-7 cells.
    Omar AM; Aboulwafa OM; Leclercq G
    J Pharm Sci; 1984 Dec; 73(12):1871-3. PubMed ID: 6441843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexible estrogen receptor modulators: design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells.
    Meegan MJ; Hughes RB; Lloyd DG; Williams DC; Zisterer DM
    J Med Chem; 2001 Mar; 44(7):1072-84. PubMed ID: 11297454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity.
    Polossek T; Ambros R; von Angerer S; Brandl G; Mannschreck A; von Angerer E
    J Med Chem; 1992 Sep; 35(19):3537-47. PubMed ID: 1404234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of 17 alpha-alkynylamide derivatives of estradiol.
    Poirier D; Labrie C; Mérand Y; Labrie F
    J Steroid Biochem Mol Biol; 1991 Jun; 38(6):759-74. PubMed ID: 2064992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of 4-methylestradiol.
    Qian XD; Abul-Hajj YJ
    J Steroid Biochem; 1990 May; 35(6):745-7. PubMed ID: 2362436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity.
    von Angerer E; Erber S
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxylic acid analogues of tamoxifen: (Z)-2-[p-(1, 2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine. Estrogen receptor affinity and estrogen antagonist effects in MCF-7 cells.
    Kraft KS; Ruenitz PC; Bartlett MG
    J Med Chem; 1999 Aug; 42(16):3126-33. PubMed ID: 10447957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytotoxic steroids with antiestrogenic activity of the 11alpha-acyloxyestra-1,3,5(10)-triene series].
    Golubovskaia LE; Smirnova ZS; Tolkachev VN; Rzheznikov VM
    Bioorg Khim; 2006; 32(2):221-3. PubMed ID: 16637294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo[a]carbazole derivatives. Synthesis, estrogen receptor binding affinities, and mammary tumor inhibiting activity.
    von Angerer E; Prekajac J
    J Med Chem; 1986 Mar; 29(3):380-6. PubMed ID: 3950918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives.
    Zablocki JA; Katzenellenbogen JA; Carlson KE; Norman MJ; Katzenellenbogen BS
    J Med Chem; 1987 May; 30(5):829-38. PubMed ID: 3033242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
    Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
    J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogues of trioxifene, [3,4-dihydro-2-(4- methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]- phenyl]methanone.
    Jones CD; Blaszczak LC; Goettel ME; Suarez T; Crowell TA; Mabry TE; Ruenitz PC; Srivatsan V
    J Med Chem; 1992 Mar; 35(5):931-8. PubMed ID: 1548683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure, and screening of estrogenic and antiestrogenic activity of new 3,17-substituted-16,17-seco-estratriene derivatives.
    Jovanović-Santa S; Petrović J; Andrić S; Kovacević R; Durendić E; Sakac M; Lazar D; Stanković S
    Bioorg Chem; 2003 Dec; 31(6):475-84. PubMed ID: 14613768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of some new diaryl and triaryl hydrazone derivatives as possible estrogen receptor modulators.
    Pandey J; Pal R; Dwivedi A; Hajela K
    Arzneimittelforschung; 2002; 52(1):39-44. PubMed ID: 11838273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
    Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
    J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonists.
    von Angerer E; Knebel N; Kager M; Ganss B
    J Med Chem; 1990 Sep; 33(9):2635-40. PubMed ID: 2391702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis by the minimum spanning tree method of the structural determinants of diphenylethylenes and triphenylacrylonitriles implicated in estrogen receptor binding, protein kinase C activity, and MCF7 cell proliferation.
    Doré JC; Gilbert J; Bignon E; Crastes de Paulet A; Ojasoo T; Pons M; Raynaud JP; Miquel JF
    J Med Chem; 1992 Feb; 35(3):573-83. PubMed ID: 1738150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptor.
    Rochefort H; Garcia M; Borgna JL
    Biochem Biophys Res Commun; 1979 May; 88(2):351-7. PubMed ID: 465043
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interaction with estrogen receptors for the control of breast neoplasia (review).
    Leclercq G; Heuson JC
    Anticancer Res; 1981; 1(4):217-28. PubMed ID: 7049050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.